132 related articles for article (PubMed ID: 32181503)
1. Clinical presentation and diagnosis of adult patients with non-Hodgkin lymphoma in Sub-Saharan Africa.
Mezger NCS; Feuchtner J; Griesel M; Hämmerl L; Seraphin TP; Zietsman A; Péko JF; Tadesse F; Buziba NG; Wabinga H; Nyanchama M; Borok MZ; Kéita M; N'da G; Lorenzoni CF; Akele-Akpo MT; Gottschick C; Binder M; Mezger J; Jemal A; Parkin DM; Wickenhauser C; Kantelhardt EJ
Br J Haematol; 2020 Jul; 190(2):209-221. PubMed ID: 32181503
[TBL] [Abstract][Full Text] [Related]
2. Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort.
Mezger NCS; Hämmerl L; Griesel M; Seraphin TP; Joko-Fru YW; Feuchtner J; Zietsman A; Péko JF; Tadesse F; Buziba NG; Wabinga H; Nyanchama M; Chokunonga E; Kéita M; N'da G; Lorenzoni CF; Akele-Akpo MT; Mezger JM; Binder M; Liu B; Bauer M; Henke O; Jemal A; Kantelhardt EJ
Oncologist; 2023 Nov; 28(11):e1017-e1030. PubMed ID: 37368350
[TBL] [Abstract][Full Text] [Related]
3. Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review.
Rees CA; Keating EM; Lukolyo H; Danysh HE; Scheurer ME; Mehta PS; Lubega J; Slone JS;
Pediatr Blood Cancer; 2016 Aug; 63(8):1325-31. PubMed ID: 27082516
[TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
[TBL] [Abstract][Full Text] [Related]
5. Non-Hodgkin lymphoma in Romania: a single-centre experience.
Fetica B; Achimas-Cadariu P; Pop B; Dima D; Petrov L; Perry AM; Nathwani BN; Müller-Hermelink HK; Diebold J; MacLennan KA; Fulop A; Blaga ML; Coza D; Nicula FA; Irimie A; Weisenburger DD
Hematol Oncol; 2017 Jun; 35(2):198-205. PubMed ID: 26482423
[TBL] [Abstract][Full Text] [Related]
6. Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?
Naresh KN; Raphael M; Ayers L; Hurwitz N; Calbi V; Rogena E; Sayed S; Sherman O; Ibrahim HA; Lazzi S; Mourmouras V; Rince P; Githanga J; Byakika B; Moshi E; Durosinmi M; Olasode BJ; Oluwasola OA; Akang EE; Akenòva Y; Adde M; Magrath I; Leoncini L
Br J Haematol; 2011 Sep; 154(6):696-703. PubMed ID: 21707579
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas.
Barrena S; Almeida J; Del Carmen García-Macias M; López A; Rasillo A; Sayagués JM; Rivas RA; Gutiérrez ML; Ciudad J; Flores T; Balanzategui A; Caballero MD; Orfao A
Histopathology; 2011 May; 58(6):906-18. PubMed ID: 21438908
[TBL] [Abstract][Full Text] [Related]
8. Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification.
Baars JW; de Jong D; Willemse EM; Gras L; Dalesio O; v Heerde P; Huygens PC; vd Lelie H; Kr vd Borne AE
Br J Cancer; 1999 Apr; 79(11-12):1770-6. PubMed ID: 10206291
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin lymphoma in Chile: a review of 207 consecutive adult cases by a panel of five expert hematopathologists.
Cabrera ME; Martinez V; Nathwani BN; Muller-Hermelink HK; Diebold J; Maclennan KA; Armitage J; Weisenburger DD
Leuk Lymphoma; 2012 Jul; 53(7):1311-7. PubMed ID: 22263570
[TBL] [Abstract][Full Text] [Related]
10. Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases.
Perry AM; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
Br J Haematol; 2016 Mar; 172(5):699-708. PubMed ID: 26684877
[TBL] [Abstract][Full Text] [Related]
11. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
[TBL] [Abstract][Full Text] [Related]
12. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
13. Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from The International Non-Hodgkin Lymphoma Classification Project.
Perry AM; Perner Y; Diebold J; Nathwani BN; MacLennan KA; Müller-Hermelink HK; Bast M; Boilesen E; Armitage JO; Weisenburger DD
Br J Haematol; 2016 Mar; 172(5):716-23. PubMed ID: 26898194
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.
Re A; Casari S; Cattaneo C; Facchetti F; Cadeo G; Carosi G; Rossi G
Cancer; 2001 Dec; 92(11):2739-45. PubMed ID: 11753946
[TBL] [Abstract][Full Text] [Related]
16. Pediatric non-Hodgkin lymphomas: first report from Central Africa.
Budiongo AN; Ngiyulu RM; Lebwaze BM; Gini-Ehungu JL; Mafuta EM; Ekulu PM; Kabongo-Mpolesha JM; Aloni MN
Pediatr Hematol Oncol; 2015 May; 32(4):239-49. PubMed ID: 25871614
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics of patients with non-hodgkin lymphoma in Arnau de Vilanova Hospital, Valencia, Spain].
Monzó Castellano E; Morales Suárez-Varela M; Mayans Ferrer J; Vila López V
An Med Interna; 2001 Dec; 18(12):629-34. PubMed ID: 11852498
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphoma.
Rossi C; Jégu J; Mounier M; Dandoit M; Colonna M; Daubisse-Marliac L; Trétarre B; Ganry O; Guizard AV; Bara S; Bouvier V; Woronoff AS; Monnereau A; Casasnovas O; Velten M; Troussard X; Maynadié M
Leuk Lymphoma; 2015; 56(10):2876-82. PubMed ID: 25641432
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India.
Manipadam MT; Nair S; Viswabandya A; Mathew L; Srivastava A; Chandy M
World J Pediatr; 2011 Nov; 7(4):318-25. PubMed ID: 21633853
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
